Pricing Log in Create free account

Bluejay Diagnostics, Inc. (BJDX) vs Intelligent Bio Solutions Inc. (INBS)

Bluejay Diagnostics, Inc. and Intelligent Bio Solutions Inc. are both Medical Devices companies. Intelligent Bio Solutions Inc. is the larger, with a market value of $4.8M against $3.5M — 1.4× the size. Intelligent Bio Solutions Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 0.9×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −294.9%) and the higher return on invested capital (0.00% vs −606.9%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 11 and Intelligent Bio Solutions Inc. on 2.

Valuation

Metric BJDX INBS Medical Devices median
P/E 0.93 n/m 23.22
P/S n/m 0.52 2.34
P/B 0.16 0.42 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 0.46 n/m 11.54
EV/Sales n/m 0.15 2.24
Earnings yield 107.76% (601.33%) (10.09%)
Free cash flow yield (405.35%) (553.24%) (8.47%)

Profitability

Metric BJDX INBS Medical Devices median
Gross margin 0.00% 48.64% 56.01%
Operating margin 0.00% (299.11%) (15.03%)
Net margin 0.00% (294.91%) (20.40%)
Free cash flow margin 0.00% (289.93%) (7.24%)
Return on equity (98.89%) (306.76%) (15.32%)
Return on assets (81.07%) (123.13%) (19.72%)
Return on invested capital 0.00% (606.86%) (10.33%)

Growth

Metric BJDX INBS Medical Devices median
Revenue growth (TTM) — 38.09% 8.80%
EPS growth (last fiscal year) 96.66% 57.80% 29.03%
Revenue growth, 5-year CAGR — 16.31% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX INBS Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 4.64 1.44 2.50
Net debt to EBITDA 0.76 0.35 0.49

Dividend

Metric BJDX INBS Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BJDX INBS Medical Devices median
Market cap 3.48m 4.78m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack